Acadia Pharmaceuticals R&D Head Elizabeth Thompson Retires Effective Oct. 23

PUBT · 1d ago
Acadia Pharmaceuticals R&D Head Elizabeth Thompson Retires Effective Oct. 23
  • ACADIA Pharmaceuticals executive vice president Elizabeth H.Z. Thompson retires as research and development head October 23, 2026, for personal reasons.
  • Thompson will become a consultant effective October 23, 2026, with limited services planned through December 31, 2026.
  • The company is seeking her replacement.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ACADIA Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-430596), on October 23, 2026, and is solely responsible for the information contained therein.